Interleukin-13 augments transforming growth factor-β1-induced tissue inhibitor of metalloproteinase-1 expression in primary human airway fibroblasts

American Journal of Physiology - Cell Physiology

Volumn 288, Issue 2 57-2, 2005, Pages

  Zhou, XiuXia ^a   Trudeau, John B ^a   Schoonover, Kathryn J ^a   Lundin, Jessica I ^a   Barnes, Steve M ^a   Cundall, Meghan J ^a   Wenzel, Sally E ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

Akt; LY 294002; Phosphatidylinositol 3 kinase

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; INTERLEUKIN 13; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FIBROBLAST; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN SYNTHESIS; RESPIRATORY TRACT MUCOSA; TIME; TRANSCRIPTION INITIATION;

1-PHOSPHATIDYLINOSITOL 4-KINASE; CELLS, CULTURED; DRUG SYNERGISM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLASTS; HUMANS; INTERLEUKIN-13; LUNG; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSFORMING GROWTH FACTOR BETA;

EID: 12144264841     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.00035.2004     Document Type: Article

References (41)

1. Alvarez GR, Zwilling BS, and Lafuse WP. Mycobacterium avium inhibition of IFN-γ signaling in mouse macrophages: toll-like receptor 2 stimulation increases expression of dominant-negative STAT1β by mRNA stabilization. J Immunol 171: 6766-6773, 2003.
2. Arico S, Petiot A, Bauvy C, Dubbelhuis PF, Meijer AJ, Codogno P, and Ogier-Denis E. The tumor suppressor PTEN positively regulates macroautophagy by inhibiting the phosphatidylinositol 3-kinase/protein kinase B pathway. J Biol Chem 276: 35243-35246, 2001.
3. Blaeser F, Bryce PJ, Ho N, Raman V, Dedeoglu F, Donaldson DD, Geha RS, Oettgen HC, and Chatila TA. Targeted inactivation of the IL-4 receptor α chain I4R motif promotes allergic airway inflammation. J Exp Med 198: 1189-1200, 2003.
4. 1 attenuates myocardial ischemia-reperfusion injury via inhibition of upregulation of MMP-1. Am J Physiol Heart Circ Physiol 284: H1612-H1617, 2003.
5. Chu HW, Halliday JL, Martin RJ, Leung DY, Szefler SJ, and Wenzel SE. Collagen deposition in large airways may not differentiate severe asthma from milder forms of the disease. Am J Respir Crit Care Med 158: 1936-1944, 1998.
6. Davies DE and Holgate ST. Asthma: the importance of epithelial mesenchymal communication in pathogenesis: inflammation and the airway epithelium in asthma. Int J Biochem Cell Biol 34: 1520-1526, 2002.
7. Gratton JP, Morales-Ruiz M, Kureishi Y, Fulton D, Walsh K, and Sessa WC. Akt down-regulation of p38 signaling provides a novel mechanism of vascular endothelial growth factor-mediated cytoprotection in endothelial cells. J Biol Chem 276: 30359-30365, 2001.
8. Hall MC, Young DA, Waters JG, Rowan AD, Chantry A, Edwards DR, and Clark IM. The comparative role of activator protein 1 and Smad factors in the regulation of Timp-1 and MMP-1 gene expression by transforming growth factor-β1. J Biol Chem 278: 10304-10313, 2003.
9. Hartness ME, Brazier SP, Peers C, Bateson AN, Ashford MLJ, and Kemp PJ. Post-transcriptional control of human maxiK potassium channel activity and acute oxygen sensitivity by chronic hypoxia. J Biol Chem 278: 51422-51432, 2003.
10. Holgate ST. Airway inflammation and remodeling in asthma: current concepts. Mol Biotechnol 22: 179-189, 2002.
11. Huaux F, Liu T, McGarry B, Ullenbruch M, and Phan SH. Dual roles of IL-4 in lung injury and fibrosis. J Immunol 170: 2083-2092, 2003.
12. Jiang H, Foltenyi K, Kashiwada M, Donahue L, Vuong B, Hehn B, and Rothman P. Fes mediates the IL-4 activation of insulin receptor substrate-2 and cellular proliferation. J Immunol 166: 2627-2634, 2001.
13. Jiang ZY, Zhou QL, Coleman KA, Chouinard M, Boese Q, and Czech MP. Insulin signaling through Akt/protein kinase B analyzed by small interfering RNA-mediated gene silencing. Proc Natl Acad Sci USA 100: 7569-7574, 2003.
14. Kelly-Welch AE, Hanson EM, Boothby MR, and Keegan AD. Interleukin-4 and interleukin-13 signaling connections maps. Science 300: 1527-1528, 2003.
15. Kim AH, Khursigara G, Sun X, Franke TF, and Chao MV. Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1. Mol Cell Biol 21: 893-901, 2001.
16. Kodera T, McGaha TL, Phelps R, Paul WE, and Bona CA. Disrupting the IL-4 gene rescues mice homozygous for the tight-skin mutation from embryonic death and diminishes TGF-β production by fibroblasts. Proc Natl Acad Sci USA 99: 3800-3805, 2002.
17. Kulik G, Klippel A, and Weber MJ. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol Cell Biol 17: 1595-1606, 1997.
18. Kumar A, Knox AJ, and Boriek AM. CCAAT/enhancer-binding protein and activator protein-1 transcription factors regulate the expression of interleukin-8 through the mitogen-activated protein kinase pathways in response to mechanical stretch of human airway smooth muscle cells. J Biol Chem 278: 18868-18876, 2003.
19. Kumar RK, Herbert C, Yang M, Koskinen AM, McKenzie AN, and Foster PS. Role of interleukin-13 in eosinophil accumulation and airway remodelling in a mouse model of chronic asthma. Clin Exp Allergy 32: 1104-1111, 2002.
20. Mautino G, Henriquet C, Jaffuel D, Bousquet J, and Capony F. Tissue inhibitor of metalloproteinase-1 levels in bronchoalveolar lavage fluid from asthmatic subjects. Am J Respir Crit Care Med 160: 324-330, 1999.
21. McKaig BC, McWilliams D, Watson SA, and Mahida YR. Expression and regulation of tissue inhibitor of metalloproteinase-1 and matrix metalloproteinases by intestinal myofibroblasts in inflammatory bowel disease. Am J Pathol 162: 1355-1360, 2003.
22. Minshall EM, Leung DY, Martin RJ, Song YL, Cameron L, Ernst P, and Hamid Q. Eosinophil-associated TGF-β1 mRNA expression and airways fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 17: 326-333, 1997.
23. Monick MM, Robeff PK, Butler NS, Flaherty DM, Carter AB, Peterson MW, and Hunninghake GW. Phosphatidylinositol 3-kinase activity negatively regulates stability of cyclooxygenase 2 mRNA. J Biol Chem 277: 32992-33000, 2002.
24. Nelms K, Keegan AD, Zamorano J, Ryan JJ, and Paul WE. The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol 17: 701-738, 1999.
25. +ββT cells. Am J Pathol 162: 263-271, 2003.
26. Overall CM, Wrana JL, and Sodek J. Independent regulation of collagenase, 72-kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-β. J Biol Chem 264: 1860-1869, 1989.
27. Reif S, Lang A, Lindquist JN, Yata Y, Gäbele E, Scanga A, Brenner DA, and Rippe RA. The role of focal adhesion kinase-phosphatidylinositol 3-kinase-Akt signaling in hepatic stellate cell proliferation and type I collagen expression. J Biol Chem 278: 8083-8090, 2003.
28. α1(I) collagen mRNA in human lung fibroblasts. Am J Physiol Cell Physiol 281: C99-C105, 2001.
29. Rolfe FG and Sewell WA. Analysis of human interleukin-5 gene transcription by a novel nuclear run on method based on the polymerase chain reaction. J Immunol Methods 202: 143-151, 1997.
30. Sagara H, Okada T, Okumura K, Ogawa H, Ra C, Fukuda T, and Nakao A. Activation of TGF-β/Smad2 signaling is associated with airway remodeling in asthma. J Allergy Clin Immunol 110: 249-254, 2002.
31. Schwertfeger KL, Richert MM, and Anderson SM. Mammary gland involution is delayed by activated Akt in transgenic mice. Mol Endocrinol 15: 867-881, 2001.
32. Spanbroek R, Hildner M, Köhler A, Müller A, Zintl F, Kühn H, Rådmark O, Samuelsson B, and Habenicht AJR. IL-4 determines eicosanoid formation in dendritic cells by down-regulation of 5-lipoxygenase and up-regulation of 15-lipoxygenase 1 expression. Proc Natl Acad Sci USA 98: 5152-5157, 2001.
33. Walker EH, Pacold ME, Perisic O, Stephens L, Hawkins PT, Wymann MP, and Williams RL. Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol Cell 6: 909-919, 2000.
34. Wenzel SE, Balzar S, Cundall M, and Chu HW. Subepithelial basement membrane immunoreactivity for matrix metalloproteinase 9: association with asthma severity, neutrophilic inflammation, and wound repair. J Allergy Clin Immunol 111: 1345-1352, 2003.
35. Wenzel SE, Balzar S, Westcott JY, Gibbs R, Chu HW, and Trudeau JB. TGF-β +IL-13 increases eotaxin in cell and mediator specific manner associated with increases in procollagen (Abstract). Am J Respir Crit Care Med 165: A730, 2002.
36. Wenzel SE, Schwartz LB, Langmack EL, Halliday JL, Trudeau JB, Gibbs RL, and Chu HW. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 160: 1001-1008, 1999.
37. Wenzel SE, Trudeau JB, Barnes S, Zhou X, Cundall M, Westcott JY, McCord K, and Chu HW. TGF-β and IL-13 synergistically increase eotaxin-1 production in human airway fibroblasts. J Immunol 169: 4613-4619, 2002.
38. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, and Donaldson DD. Interleukin-13: central mediator of allergic asthma. Science 282: 2258-2261, 1998.
39. Yang M, Hogan SP, Henry PJ, Matthaei KI, McKenzie ANJ, Young IG, Rothenberg ME, and Foster PS. Interleukin-13 mediates airways hyperreactivity through the IL-4 receptor-α chain and STAT-6 independently of IL-5 and eotaxin. Am J Respir Cell Mol Biol 25: 522-530, 2001.
40. Yang YY, Tsai HF, Lu SC, Huang YF, and Chang YC. Regulation of tissue inhibitors of metalloproteinase-1 gene expression by cytokines in human gingival fibroblasts. J Endod 28: 803-805, 2002.
41. Zhou X, Schoonover KJ, Barns SM, Cundall MJ, and Wenzel SE. Synergistic increase in eotaxin-1 production through TGF-β1 and IL-13 activated STAT-6 pathway in primary human airway fibroblasts (Abstract). FASEB J 17: A1357, 2003.